BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 19522833)

  • 21. The inhibitory effect of leptin on angiotensin II-induced vasoconstriction is blunted in spontaneously hypertensive rats.
    Rodríguez A; Frühbeck G; Gómez-Ambrosi J; Catalán V; Sáinz N; Díez J; Zalba G; Fortuño A
    J Hypertens; 2006 Aug; 24(8):1589-97. PubMed ID: 16877962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fat intake modifies vascular responsiveness and receptor expression of vasoconstrictors: implications for diet-induced obesity.
    Mundy AL; Haas E; Bhattacharya I; Widmer CC; Kretz M; Hofmann-Lehmann R; Minotti R; Barton M
    Cardiovasc Res; 2007 Jan; 73(2):368-75. PubMed ID: 17166491
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impaired extracellular matrix degradation in aortic vessels of cirrhotic rats.
    Fernández-Varo G; Morales-Ruiz M; Ros J; Tugues S; Muñoz-Luque J; Casals G; Arroyo V; Rodés J; Jiménez W
    J Hepatol; 2007 Mar; 46(3):440-6. PubMed ID: 17156884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Angiotensin II up-regulates the leukemia-associated Rho guanine nucleotide exchange factor (RhoGEF), a regulator of G protein signaling domain-containing RhoGEF, in vascular smooth muscle cells.
    Ying Z; Jin L; Palmer T; Webb RC
    Mol Pharmacol; 2006 Mar; 69(3):932-40. PubMed ID: 16354763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peroxisome proliferator-activated receptor alpha activation attenuated angiotensin type 1-mediated but enhanced angiotensin type 2-mediated hemodynamic effects to angiotensin II in the rat.
    Banks T; Oyekan A
    J Hypertens; 2008 Mar; 26(3):468-77. PubMed ID: 18300857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of ET-1 on isolated perfused rat liver and vascular rings at two stages of cirrhosis].
    Yao D; Yao X; Yang C; Feng Z; Fang H; Gao J
    Zhonghua Yi Xue Za Zhi; 2002 Nov; 82(22):1565-8. PubMed ID: 12609069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Opposing roles of endothelial and smooth muscle phosphatidylinositol 3-kinase in vasoconstriction: effects of rho-kinase and hypertension.
    Budzyn K; Marley PD; Sobey CG
    J Pharmacol Exp Ther; 2005 Jun; 313(3):1248-53. PubMed ID: 15743931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II receptors subtypes mediate diverse gene expression profile in adult hypertrophic cardiomyocytes.
    Zhou J; Xu X; Liu JJ; Lin YX; Gao GD
    Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1191-8. PubMed ID: 17880376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Tarsitano CA; Paffaro VA; Pauli JR; da Silva GH; Saad MJ; Salgado I; da Cruz-Höfling MA; Hyslop S
    Cell Tissue Res; 2007 Jul; 329(1):45-58. PubMed ID: 17436021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of myosin light chain kinase expression by angiotensin II in hypertension.
    Han YJ; Hu WY; Piano M; de Lanerolle P
    Am J Hypertens; 2008 Aug; 21(8):860-5. PubMed ID: 18511912
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of angiotensin II and its metabolites in the rat coronary vascular bed: is angiotensin III the preferred ligand of the angiotensin AT2 receptor?
    van Esch JH; Oosterveer CR; Batenburg WW; van Veghel R; Jan Danser AH
    Eur J Pharmacol; 2008 Jul; 588(2-3):286-93. PubMed ID: 18511032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
    Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
    Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diguanosine pentaphosphate: an endogenous activator of Rho-kinase possibly involved in blood pressure regulation.
    Tölle M; Giebing G; Tietge UJ; Jankowski J; Jankowski V; Henning L; Hörl MP; Weiss W; Zidek W; van der Giet M
    J Hypertens; 2006 Oct; 24(10):1991-2000. PubMed ID: 16957559
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Desensitization of G-protein-coupled receptors induces vascular hypocontractility in response to norepinephrine in the mesenteric arteries of cirrhotic patients and rats.
    Chen W; Sang JY; Liu DJ; Qin J; Huo YM; Xu J; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):295-304. PubMed ID: 23742775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sorafenib targets dysregulated Rho kinase expression and portal hypertension in rats with secondary biliary cirrhosis.
    Hennenberg M; Trebicka J; Stark C; Kohistani AZ; Heller J; Sauerbruch T
    Br J Pharmacol; 2009 May; 157(2):258-70. PubMed ID: 19338580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reactive oxygen species are involved in regulating hypocontractility of mesenteric artery to norepinephrine in cirrhotic rats with portal hypertension.
    Chen W; Liu DJ; Huo YM; Wu ZY; Sun YW
    Int J Biol Sci; 2014; 10(4):386-95. PubMed ID: 24719556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A quantitative study on vascular angiotensin II receptors in rats with portal hypertension.
    Li J; Dai Z; Cui W; Hu Y
    J Tongji Med Univ; 1997; 17(4):235-8. PubMed ID: 9812788
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of angiotensin-(1-7) and angiotensin II on vascular tone in human cirrhotic splanchnic vessels.
    Casey S; Herath C; Rajapaksha I; Jones R; Angus P
    Peptides; 2018 Oct; 108():25-33. PubMed ID: 30179652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Vascular reactivity and receptor expression of endogenous vasoconstrictor in rats with alcoholic cardiomyopathy and insulation stress].
    Kozhevnikova LM; Tsorin IB; Varkov AI; Stolyaruk VN; Vititnova MB; Kolik LG; Sukhanova IF; Kryzhanovskii SA
    Patol Fiziol Eksp Ter; 2015; 59(4):45-57. PubMed ID: 27116878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cirrhosis of the liver and receptor-mediated function in vascular smooth muscle.
    Hadoke PW
    Pharmacol Ther; 2001 Mar; 89(3):233-54. PubMed ID: 11516478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.